Search

1. Belimumab and voclosporin for lupus nephritis: final policy recommendations

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, April 16, 2021

Subject(s):

Calcineurin Inhibitors
Immunosuppressive Agents
Lupus Nephritis -- drug therapy
United States

2. Belimumab and voclosporin for lupus nephritis: effectiveness and value : final report

Author(s):

Tice, Jeffrey A., author
Agboola, Foluso, author
Herron-Smith, Serina, author
Chapman, Rick, (Of Institute for Clinical and Economic Review), author
Pearson, Steven D., author
Mandrik, Olena, author
Thokala, P. (Praveen), author
Fotheringham, James, (Of University of Sheffield), author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, April 16, 2021

Subject(s):

Antibodies, Monoclonal, Humanized
B-Cell Activating Factor -- antagonists & inhibitors
Calcineurin Inhibitors -- therapeutic use
Cyclosporine -- therapeutic use
Immunosuppressive Agents -- therapeutic use
Lupus Nephritis -- drug therapy
Treatment Outcome
United States